Medicare Enrolled

Dr. Nancy Nicolosi, NP-C

Nurse Practitioner - Adult Health · Laguna Woods, CA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
24331 EL TORO RD, Laguna Woods, CA 92637
9495830222
In practice since 2016 (10 years)
NPI: 1598122087 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Nicolosi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Nicolosi? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Nicolosi

Dr. Nancy Nicolosi is a nurse practitioner - adult health in Laguna Woods, CA, with 10 years of NPI registration. Based on federal Medicare data, Dr. Nicolosi performed 12,193 Medicare services across 176 unique beneficiaries.

Between the years covered by Open Payments, Dr. Nicolosi received a total of $18,492 from 24 pharmaceutical and/or device companies across 637 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in nurse practitioner - adult health. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Nicolosi is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 10 years in practice ▲ Top 1% volume in CA $18,492 industry payments

Medicare Practice Summary

Medicare Utilization ↗
12,193
Medicare services
Top 1% in CA for nurse practitioner - adult health
176
Unique beneficiaries
$11
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~1,219 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Tocilizumab injection (Actemra) 8,400 $5 $17
Golimumab infusion (Simponi Aria)
Administration of golimumab medication directly into a vein. This code specifies the dosage amount of 1 milligram for intravenous delivery.
1,900 $11 $42
Abatacept infusion (Orencia)
An injection of abatacept administered under the direct supervision of a physician. This code is used for Medicare when the drug is not self-administered.
1,725 $34 $127
Intravenous chemotherapy infusion, 1 hour or less
Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete.
58 $103 $554
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
49 $93 $206
Non-hormonal chemotherapy injection
This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue.
26 $57 $262
Additional hour of intravenous chemotherapy
This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period.
19 $22 $259
Telephone medical discussion, 5-10 minutes
A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters.
16 $42 $92
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
30.2% high complexity
69.3% medium
0.5% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$18,492
Total received (2021-2024)
Avg $4,623/year across 4 years
Top 2% in CA for nurse practitioner - adult health
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
24
Companies
637
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,757 (74.4%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$4,735 (25.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$6,164
2023
$6,359
2022
$2,792
2021
$3,177

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Janssen Biotech, Inc.
$2,372
Amgen Inc.
$807
ABBVIE INC.
$806
AstraZeneca Pharmaceuticals LP
$572
Lilly USA, LLC
$523
Novartis Pharmaceuticals Corporation
$204
GlaxoSmithKline, LLC.
$141
PFIZER INC.
$136
UCB, Inc.
$127
E.R. Squibb & Sons, L.L.C.
$117
Boehringer Ingelheim Pharmaceuticals, Inc.
$114
Radius Health, Inc.
$99
Fresenius Kabi USA, LLC
$63
Octapharma USA, Inc.
$44
Mallinckrodt Hospital Products Inc.
$21
Organon Llc
$19
Top 3 companies account for 64.6% of 2024 payments
All-time payments by company (2021-2024) ›
Janssen Biotech, Inc.
$3,420
Amgen Inc.
$3,272
AstraZeneca Pharmaceuticals LP
$3,079
ABBVIE INC.
$2,607
Lilly USA, LLC
$1,686
Horizon Therapeutics plc
$710
AbbVie Inc.
$501
GlaxoSmithKline, LLC.
$489
Boehringer Ingelheim Pharmaceuticals, Inc.
$470
Novartis Pharmaceuticals Corporation
$453
PFIZER INC.
$423
UCB, Inc.
$408
Radius Health, Inc.
$323
Fresenius Kabi USA, LLC
$143
E.R. Squibb & Sons, L.L.C.
$117
Alvogen Inc
$86
Aurinia Pharma U.S., Inc.
$73
Octapharma USA, Inc.
$66
Ultragenyx Pharmaceutical Inc.
$56
Alexion Pharmaceuticals, Inc.
$28
Cumberland Pharmaceuticals, Inc.
$23
Mallinckrodt Hospital Products Inc.
$21
GENZYME CORPORATION
$19
Organon Llc
$19
Top 3 companies account for 52.8% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AVSOLA · BENLYSTA · Bimzelx · COSENTYX · CRYSViTA · CYLTEZO · Cimzia · EVENITY · Enbrel · HADLIMA · HUMIRA · IDACIO · KEVZARA · KRYSTEXXA · LUPKYNIS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OFEV · ORENCIA · Otezla · PANZYGA · RAYOS · REDITREX · REMICADE · RINVOQ · SAPHNELO · SIMPONI ARIA · SKYRIZI · STRENSIQ · TALTZ · TAVNEOS · TERIPARATIDE · TREMFYA · Tavneos · Tymlos · XELJANZ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (74%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 2% for nurse practitioner - adult health in CA.

Looking for a nurse practitioner - adult health in Laguna Woods?
Compare adult-health nurse practitioners in the Laguna Woods area by procedure volume, costs, and industry payment transparency.
Browse adult-health nurse practitioners nearby

Geographic Context

Adult-health nurse practitioners within 10 mi
123
Per 100K population
3.9
County median income
$113,702
Nearest hospital
MEMORIALCARE SADDLEBACK MEDICAL CENTER
1.8 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Nicolosi is a mixed practice specialist, with above-average Medicare volume (top 1% in CA), with low-engagement industry engagement in the top 2% of CA peers.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Nicolosi experienced with tocilizumab injection (actemra)?
Based on Medicare claims data, Dr. Nicolosi performed 8,400 tocilizumab injection (actemra) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Nicolosi receive payments from pharmaceutical companies?
Yes. Dr. Nicolosi received a total of $18,492 from 24 companies across 637 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Nicolosi's costs compare to other adult-health nurse practitioners in Laguna Woods?
Dr. Nicolosi's average Medicare payment per service is $11. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Nicolosi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →